Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$408,011
-$67,355 QoQ
Shares Held
16,944
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,897
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Newman Dignan & Sheerar, Inc. holds $16,082,023 across 8 Drug Manufacturers - General names. PFE ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,236 | $5,393,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
28,738 | $3,692,833 | |
| 3 | AMGN |
Amgen Inc
|
7,582 | $2,745,593 | |
| 4 | LLY |
ELI LILLY & Co
|
1,043 | $1,251,005 | |
| 5 | ABBV |
AbbVie Inc.
|
4,147 | $1,043,551 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,344 | $999,361 | |
| 7 | NVS |
Novartis AG
|
3,499 | $548,363 | |
| 8 | PFE |
Pfizer Inc
This page
|
16,944 | $408,011 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $408,011 | 16,944 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $475,366 | 16,929 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $435,700 | 17,498 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $398,201 | 15,628 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $379,234 | 15,645 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $436,177 | 17,213 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $462,550 | 17,435 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $525,000 | 18,141 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $545,078 | 19,481 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $560,855 | 20,211 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $677,946 | 23,548 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,039,083 | 31,326 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,200,976 | 32,742 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,335,506 | 32,733 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,681,901 | 32,824 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,466,660 | 33,516 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $1,743,035 | 33,245 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,735,848 | 33,530 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,994,472 | 33,776 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,452,576 | 33,773 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,328,385 | 33,922 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,109,543 | 30,625 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,201,920 | 32,652 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,198,033 | 32,644 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $1,051,109 | 32,144 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $991,699 | 30,383 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||